5am Venture Management, LLC / CRNX
5am Venture Management, LLC’s Crinetics Pharmaceuticals In Position
Does 5am Venture Management, LLC own Crinetics Pharmaceuticals In (CRNX)? Not currently — the last reported position was 462.3K shares worth $14M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$14M
Q3 2023
Shares
462.3K
% of Portfolio
+3.96%
Quarters Held
16
position exited
Position History CRNX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 462.3K | $14M | +3.96% |
| Q2 2023 | 862.3K | $16M | +3.87% |
| Q1 2023 | 862.3K | $14M | +3.54% |
| Q4 2022 | 862.3K | $16M | +4.24% |
| Q3 2022 | 862.3K | $17M | +3.24% |
| Q2 2022 | 862.3K | $16M | +3.98% |
| Q1 2022 | 862.3K | $19M | +4.13% |
| Q4 2021 | 862.3K | $24M | +4.60% |
| Q3 2021 | 1.36M | $29M | +5.82% |
| Q2 2021 | 1.36M | $26M | +6.46% |
| Q1 2021 | 1.36M | $21M | +3.75% |
| Q4 2020 | 1.36M | $19M | +6.47% |
| Q3 2020 | 1.36M | $21M | +5.61% |
| Q2 2020 | 1.36M | $24M | +5.23% |
| Q1 2020 | 1.86M | $27M | +8.48% |
| Q4 2019 | 2.36M | $59M | +12.75% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See 5am Venture Management, LLC’s full portfolio or all institutional holders of CRNX.